The information level of parents about rotavirus gastroenteritis and rotavirus vaccine and the incidence of rotavirus vaccination in Ankara
Ankara’da ebeveynlerin rotavirüs hakkında bilgi düzeyleri ve çocukların rotavirüs aşılanma oranları
Abstract views: 94 / PDF downloads: 67
DOI:
https://doi.org/10.5455/GMJ-30-2012-104Keywords:
Gastroenteritis, rotavirus, vaccinationAbstract
The aim of the study was to determine the information level of parents about rotavirus gastroenteritis, rotavirus vaccine, and the incidence of rotavirus vaccination in Ankara. 500 patients with the age of more than 4 months who admitted to our outpatient clinic in 2010 and 2011 were included in this study. We asked parents whether they have any information about rotavirus gastroenteritis and rotavirus vaccine, and their children had the first dose of rotavirus vaccination or not. When the patients’ answers were negative we asked for the reason. In 2010, of these 250 parents; 19,2% (48/250) had information about rotavirus gastroenteritis and rotavirus vaccine and 6,4% (16/250) had the first dose of rotavirus vaccination. The ratio of rotavirus vaccination among parents who had an information about rotavirus gastroenteritis and rotavirus vaccine was 33,3% (16/48). In 2011; 24,8% (62/250 ) of parents have information about rotavirus gastroenteritis and rotavirus vaccine; 10,4% (26/250) had the first dose of rotavirus vaccination and 41,9% (26/62) of parents who had information about rotavirus gastroenteritis and rotavirus vaccine had rotavirus vaccination. In 2010; nonconfidence for rotavirus vaccines (27,1%;13/48) and high costs (72,9%;35/48) and in 2011; non-confidence for rotavirus vaccines (17,7%;11/66) and high costs (82,3%;55/66) were the reasons of not having vaccinated. The information level of the parents about rotavirus gastroenteritis, rotavirus vaccine, and the incidence of rotavirus vaccination rates were low. To prevent rotavirus gastroenteritis, an important cause of diarrhea, parents should be informed about this vaccination and rotavirus vaccine should be taken into the national immunization program.
Metrics
References
Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003;9:565-72.
Clark HF, Glass RI, Offitt PA. Rotavirus vaccines. In plotkin SA, Orenstein WA(eds). Vaccines, 3rd ed. Philadelphia, WB Saunders, 1999,987-1005
Kapikan AZ, Chanock RM. Rotaviruses. In Fields BN, Knipe DM, Howley PM, et al (eds). Fields Virology (3rd ed). Vol.2. Philadelphia, Lippincoot-Raven, 1996;1657-708
Parashar UD, Gibson CJ, Bresee JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006;12:304-6.
Black RE, Cousens S, Johnson HL, Perin J, Scott S, Rudan I, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010;375(9730):1969-87.
Bozdayi G, Dogan B, Dalgic B, Bostanci I, Sari S, Battaloglu NO, et al. Diversity of human rotavirus G9 among children in Turkey. J Med Virol 2008;80(4):733-40.
Kurugol Z, Geylani S, Karaca Y, Umay F, Erensoy S, Vardar F, et al. Rotavirus gastroenteritis among children under five yearsof age in Izmir, Turkey. Turkish J Pediatr 2003;45(4):290- 4.
Cataloluk O, Iturriza M, Gray J. Molecular characterization of rotaviruses circulating in the population in Turkey. Epidemiol Infect 2005;133(4):673-8.
Ceyhan M, Alhan E, Salman N, Kurugol Z, Yildirim I, Celik U, et al. Multicenter prospective study on the burden of rotavirus gastroenteritis in Turkey, 2005-2006: a hospital-based study. J Infect Dis 2009;200(Suppl 1):234-8.
Kurugöl Z, Salman N. Rotavirus infeksiyonları ve aşıları. ANKEM 2008;22(3):160-70.
Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005;15(1):29-56.
Kurugöl Z. Rotavirus Vaccines, J Pediatr Inf; 2011;5(suppl 1): 163-7.
Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010;375(9730):1969-87.
Yarkın F. Gastroenterit virusları. In: Ustaçelebi Ş, Abacıoğlu H, Badur S, eds. Moleküler, Klinik ve Tanısal Viroloji. Ankara: Güneş Kitabevi, 2004:245-9.
Moon HW. Pathophysiology of viral diarrhea. In: Kapikian AZ (ed), Viral Infections of the Gastrointestinal Tract., 2nd ed. Marcel Dekker Inc, New York. 1994;27-52.
Saronio-Gabarro MS, Mrukowicz J, Vesikari T, Verstraeten T. Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J 2006;25(Suppl 1):7-11.
Glass RI, Kilgore PE, Holman RC, Jin S, Smith JC, Woods PA, et al. The epidemiology of rotavirus diarrhoea in the United States: surveillance and of disease burden. J Infect Dis 1996;174(suppl 1):5-11.
Karadag A, Acikgoz ZC, Avci Z, Catal F, Gocer S, Gamberzade S, et al. Childhood diarrhoea in Ankara, Turkey: epidemiological and clinical features of rotavirus-positive versus rotavirus-negative cases. Scand J Infect Dis 2005;37(4):269 -75.
Nazik H, İlktaç M, Öngen B. Çocukluk yaş grubu gastroenteritlerinde rotavirus sıklığının araştırılması. ANKEM 2006;20(4):233-5.
Biçer S, Şahin GT, Koncay B, Yavuzcan D, Gemici H, Engerek N, ve ark. Çocuk acil servisinde saptanan rotavirus gastroenteriti olgularının sıklığı. Çocuk Enfeksiyon Derg 2008;2(3):96-9.
Ceyhan M, Kanra G, Yeniay I, Ciliv G, Vesikari T. Rotaviruses in infants with diarrhea studied by viral RNA electrophoresis in Ankara, Turkey. Turk J Pediatr 1987;29:145-9.
Altındiş M, Yavru S, Şimşek A, Özkul A, Çeri A, Koç H. Rotavirus infection in children with acute diarrhea as detected by latex agglutination, ELISA and polyacrylamide gel electrophoresis. Indian Pediatr 2004;41:590-4.
Ministry of Health, Refik Saydam Hygiene Center Presidency. School of Public Health. Burden of disease, final report. 1st edition. Ankara, Turkey.2004;1-446. ,
Lepage P. Rotavirus. Evidence for vaccination. Pediatr Infect Dis J 2008;27:1-2.
Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campell S, et al. Rotavirus infections in infants as protection against subsequent infections. N Eng J Med 1996;405:1022-8.
Ward RL, Bernstein DI. Protection against rotavirus disease after natural rotavirus infection. US Rotavirus Vaccine Efficacy Group. J Infect Dis 1994;169:900-4.
CDC.Press release of the Centers for Disease Control and Prevention, February 21,2006.
AAP. Prevention of Rotavirus Disease: Guidelines for Use of Rotavirus Vaccine. Committee on Infectious Diseases. Pediatrics 2007;119:171-82.
CDC. National Respiratory and Enteric Virus Surveillance System. MMWR 2008;57.
Ruiz Palacios G, Perez Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354:11-22.
Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354:23-40.
Hacımustafaoğlu M. Routine Immunisation Schedule In Turkey; expanded Immunisation Schedule. J pediatr Inf 2011; 5 (Suppl 1): 244-51.
AAP. Prevention of Rotavirus Disease: Guidelines for Use of Rotavirus Vaccine. Committee of Infectious Diseas. Pediatrics 2007;119:171-82.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 European Journal of Therapeutics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.